Compare CATX & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CATX | EMD |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.6M | 561.5M |
| IPO Year | 2018 | N/A |
| Metric | CATX | EMD |
|---|---|---|
| Price | $4.42 | $9.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.11 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 267.2K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.71 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $8.56 |
| 52 Week High | $6.16 | $11.30 |
| Indicator | CATX | EMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.08 | 38.88 |
| Support Level | $3.24 | N/A |
| Resistance Level | $4.54 | $10.56 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 34.92 | 35.06 |
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management and long term investment company. The primary investment objective of the company is to seek high current income, and the secondary objective is to seek capital appreciation.